Cargando…
Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
Autores principales: | Kırcalı, Ekin, Ermiş, Gül Yavuz, Öztürk, Cemaleddin, Yilmaz, Hülya, Seval, Guldane Cengiz, Yıldırım, Yasin, Bozdag, Sinem Civriz, Toprak, Selami Kocak, Topcuoglu, Pervin, Ilhan, Osman, Beksac, Meral, Gurman, Gunhan, Yuksel, Meltem Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930036/ http://dx.doi.org/10.1016/S2666-6367(22)00500-0 |
Ejemplares similares
-
Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
por: Kırcalı, Ekin, et al.
Publicado: (2023) -
White Matter Tract Changes Associated with Clinical Improvement in an Open‐Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism
por: Carpenter, Kimberly L. H., et al.
Publicado: (2019) -
Umbilical Cord Blood Units Cryopreserved in the Public Cord Blood Bank: A Breakthrough in iPSC Haplobanking?
por: Roh, Eun Youn, et al.
Publicado: (2020) -
Human cord blood‐derived regulatory T‐cell therapy modulates the central and peripheral immune response after traumatic brain injury
por: Caplan, Henry W., et al.
Publicado: (2020) -
Autologous cord blood cell infusion in preterm neonates safely reduces respiratory support duration and potentially preterm complications
por: Ren, Zhuxiao, et al.
Publicado: (2019)